Compare EVR & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVR | FMS |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Investment Managers | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.5B |
| IPO Year | 2006 | 1996 |
| Metric | EVR | FMS |
|---|---|---|
| Price | $337.07 | $23.56 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | ★ $326.56 | $30.00 |
| AVG Volume (30 Days) | 345.8K | ★ 450.8K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | 1.00% | ★ 2.42% |
| EPS Growth | ★ 61.11 | 8.62 |
| EPS | ★ 12.55 | 2.86 |
| Revenue | $3,542,875,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $25.39 | $2.12 |
| Revenue Next Year | $16.43 | $2.92 |
| P/E Ratio | $26.85 | ★ $15.93 |
| Revenue Growth | ★ 27.03 | 2.10 |
| 52 Week Low | $148.63 | $22.05 |
| 52 Week High | $364.42 | $30.46 |
| Indicator | EVR | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 61.16 | 45.83 |
| Support Level | $319.69 | $22.63 |
| Resistance Level | $349.91 | $24.20 |
| Average True Range (ATR) | 10.83 | 0.27 |
| MACD | 2.97 | 0.10 |
| Stochastic Oscillator | 72.03 | 59.23 |
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.